Phreesia (NYSE:PHR) Shares Down 5.7%

Phreesia, Inc. (NYSE:PHR) shares dropped 5.7% during mid-day trading on Wednesday . The company traded as low as $21.71 and last traded at $21.82. Approximately 292,763 shares traded hands during mid-day trading, a decline of 43% from the average daily volume of 514,009 shares. The stock had previously closed at $23.14.

Analyst Ratings Changes

Several equities analysts have weighed in on PHR shares. Barclays started coverage on shares of Phreesia in a report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price target on the stock. DA Davidson reissued a “neutral” rating and issued a $32.00 target price on shares of Phreesia in a report on Friday, March 15th. Stephens reissued an “overweight” rating and issued a $28.00 target price on shares of Phreesia in a report on Friday, March 22nd. Needham & Company LLC reissued a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Friday, March 15th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a report on Thursday, March 21st. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $31.62.

Phreesia Trading Down 5.2 %

The stock’s 50 day moving average is $24.08 and its two-hundred day moving average is $21.40. The company has a market capitalization of $1.24 billion, a PE ratio of -8.64 and a beta of 0.92. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.58) by $0.02. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The company had revenue of $95.00 million during the quarter, compared to analyst estimates of $93.52 million. During the same period in the prior year, the firm earned ($0.72) earnings per share. The firm’s revenue for the quarter was up 24.0% compared to the same quarter last year. As a group, sell-side analysts predict that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Insider Activity

In related news, SVP Amy Beth Vanduyn sold 3,354 shares of the stock in a transaction that occurred on Monday, April 8th. The shares were sold at an average price of $22.62, for a total value of $75,867.48. Following the transaction, the senior vice president now owns 123,463 shares in the company, valued at approximately $2,792,733.06. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, General Counsel Allison C. Hoffman sold 5,549 shares of the stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $22.62, for a total transaction of $125,518.38. Following the transaction, the general counsel now owns 141,485 shares in the company, valued at approximately $3,200,390.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Amy Beth Vanduyn sold 3,354 shares of the stock in a transaction that occurred on Monday, April 8th. The shares were sold at an average price of $22.62, for a total value of $75,867.48. Following the transaction, the senior vice president now owns 123,463 shares in the company, valued at approximately $2,792,733.06. The disclosure for this sale can be found here. Insiders have sold a total of 82,989 shares of company stock worth $1,911,735 over the last 90 days. 5.80% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. International Assets Investment Management LLC lifted its holdings in Phreesia by 1,987.3% in the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after purchasing an additional 1,411 shares in the last quarter. Acadian Asset Management LLC acquired a new stake in shares of Phreesia in the 3rd quarter worth $53,000. Russell Investments Group Ltd. increased its stake in shares of Phreesia by 5,462.3% in the 4th quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock worth $89,000 after acquiring an additional 3,769 shares during the last quarter. SG Americas Securities LLC acquired a new stake in shares of Phreesia in the 3rd quarter worth $132,000. Finally, Counterpoint Mutual Funds LLC acquired a new stake in shares of Phreesia in the 3rd quarter worth $137,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.